BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Posch W, Vosper J, Zaderer V, Noureen A, Constant S, Bellmann-Weiler R, Lass-Flörl C, Wilflingseder D. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia. mBio 2021;12:e00904-21. [PMID: 33906927 DOI: 10.1128/mBio.00904-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaderer V, Dichtl S, Posch W, Abiatari I, Bonn GK, Jakschitz T, Huber LA, Kurzchalia TV, Wilflingseder D. GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events. Respir Res 2023;24:88. [PMID: 36949547 DOI: 10.1186/s12931-023-02397-3] [Reference Citation Analysis]
2 Bayerl F, Bejarano DA, Bertacchi G, Doffin AC, Gobbini E, Hubert M, Li L, Meiser P, Pedde AM, Posch W, Rupp L, Schlitzer A, Schmitz M, Schraml BU, Uderhardt S, Valladeau-Guilemond J, Wilflingseder D, Zaderer V, Böttcher JP. Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods. Eur J Immunol 2023;:e2249923. [PMID: 36623939 DOI: 10.1002/eji.202249923] [Reference Citation Analysis]
3 Nocini R, Henry BM, Mattiuzzi C, Lippi G. Improving Nasal Protection for Preventing SARS-CoV-2 Infection. Biomedicines 2022;10. [PMID: 36428534 DOI: 10.3390/biomedicines10112966] [Reference Citation Analysis]
4 Williamson S, Dennison L, Greenwell K, Denison-Day J, Mowbray F, Richards-Hall S, Smith D, Bradbury K, Ainsworth B, Little P, Geraghty AWA, Yardley L. Using nasal sprays to prevent respiratory tract infections: a qualitative study of online consumer reviews and primary care patient interviews. BMJ Open 2022;12:e059661. [PMID: 35772824 DOI: 10.1136/bmjopen-2021-059661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang K, Yu Y, Han R, Wang X, Zhao Y, Tang H, Li G. [Establishment of a culture system for human nasal mucosa organoids with controllable differentiation]. Nan Fang Yi Ke Da Xue Xue Bao 2022;42:868-77. [PMID: 35790437 DOI: 10.12122/j.issn.1673-4254.2022.06.10] [Reference Citation Analysis]
6 Wilflingseder D, Posch W. Wie sich COVID-19 in der 3D-Zellkultur simulieren lässt. Biospektrum 2022;28:43-46. [DOI: 10.1007/s12268-022-1712-y] [Reference Citation Analysis]
7 Zaderer V, Dichtl S, Bellmann Weiler R, Lass Flörl C, Posch W, Wilflingseder D. ColdZyme® protects airway epithelia from infection with BA.4/5. Respir Res 2022;23:300. [PMID: 36316674 DOI: 10.1186/s12931-022-02223-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mather MW, Jardine L, Talks B, Gardner L, Haniffa M. Complexity of immune responses in COVID-19. Semin Immunol 2021;55:101545. [PMID: 34865933 DOI: 10.1016/j.smim.2021.101545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zaderer V, Posch W, Gstir R, Filipek PA, Bonn GK, Aramwit P, Huber LA, Wilflingseder D. P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCs. Vaccines (Basel) 2021;9:976. [PMID: 34579213 DOI: 10.3390/vaccines9090976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]